US-based medical device company Neuronetics closed a $34.3m series F round yesterday backed by Pfizer Venture Investments and GE Ventures, the respective corporate venturing arms of drugs producer Pfizer and conglomerate General Electric.
The company did not disclose the other investors in the round, disclosing only that the syndicate consisted of its original investor base.
Apart from Pfizer, Neuronetics’ existing investors are Polaris Venture Partners, Investor Growth Capital, New Leaf Venture Partners, Three Arch Partners, Interwest Partners, Onset Ventures, Quaker…
